BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27619562)

  • 1. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.
    Filichia E; Hoffer B; Qi X; Luo Y
    Sci Rep; 2016 Sep; 6():32656. PubMed ID: 27619562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson's disease.
    Zhang Q; Hu C; Huang J; Liu W; Lai W; Leng F; Tang Q; Liu Y; Wang Q; Zhou M; Sheng F; Li G; Zhang R
    Exp Mol Med; 2019 Oct; 51(10):1-13. PubMed ID: 31578315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Essential Role of Drp1 and Its Regulation by S-Nitrosylation of Parkin in Dopaminergic Neurodegeneration: Implications for Parkinson's Disease.
    Zhang Z; Liu L; Jiang X; Zhai S; Xing D
    Antioxid Redox Signal; 2016 Oct; 25(11):609-622. PubMed ID: 27267045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.
    Qi X; Qvit N; Su YC; Mochly-Rosen D
    J Cell Sci; 2013 Feb; 126(Pt 3):789-802. PubMed ID: 23239023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1.
    Geng J; Liu W; Gao J; Jiang C; Fan T; Sun Y; Qin ZH; Xu Q; Guo W; Gao J
    Br J Pharmacol; 2019 Dec; 176(23):4574-4591. PubMed ID: 31389613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
    J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.
    Kim DI; Lee KH; Gabr AA; Choi GE; Kim JS; Ko SH; Han HJ
    Biochim Biophys Acta; 2016 Nov; 1863(11):2820-2834. PubMed ID: 27599716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation.
    Su YC; Qi X
    Hum Mol Genet; 2013 Nov; 22(22):4545-61. PubMed ID: 23813973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.
    Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC
    Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease.
    Portz P; Lee MK
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Drp1 provides neuroprotection in vitro and in vivo.
    Grohm J; Kim SW; Mamrak U; Tobaben S; Cassidy-Stone A; Nunnari J; Plesnila N; Culmsee C
    Cell Death Differ; 2012 Sep; 19(9):1446-58. PubMed ID: 22388349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment.
    Chuang JI; Pan IL; Hsieh CY; Huang CY; Chen PC; Shin JW
    J Pineal Res; 2016 Sep; 61(2):230-40. PubMed ID: 27159033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
    Lee Y; Heo G; Lee KM; Kim AH; Chung KW; Im E; Chung HY; Lee J
    Brain Res; 2017 May; 1663():184-193. PubMed ID: 28322751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.
    Stahl K; Rahmani S; Prydz A; Skauli N; MacAulay N; Mylonakou MN; Torp R; Skare Ø; Berg T; Leergaard TB; Paulsen RE; Ottersen OP; Amiry-Moghaddam M
    PLoS One; 2018; 13(3):e0194896. PubMed ID: 29566083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.
    Guo X; Disatnik MH; Monbureau M; Shamloo M; Mochly-Rosen D; Qi X
    J Clin Invest; 2013 Dec; 123(12):5371-88. PubMed ID: 24231356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.